We have previously demonstrated that IL-13-PE is a powerful anti-cancer agent, causing regression of IL-13Rα2-positive human tumors derived from variety of human cancers including pancreatic cancer [15,16]. This evidence concerns the gene IL13RA2 and familial pancreatic carcinoma.